Search
for
Sort by
Research 481–510 of 1000+
- Endogenous neurosteroids modulate epileptogenesis in a model of temporal lobe epilepsy
- Neurosteroids and epileptogenesis in the pilocarpine model: Evidence for a relationship between P450scc induction and length of the latent period
- Onychomatricoma in the Light of the Microanatomy of the Normal Nail Unit
- Psoriasis patients demonstrate HLA-Cw*06:02 allele dosage-dependent T cell proliferation when treated with hair follicle-derived keratin 17 protein
- Emergence of the natural history of Myhre syndrome: 47 patients evaluated in the Massachusetts General Hospital Myhre Syndrome Clinic (2016–2023)
- Molecular Mechanisms in the Etiology of Polycystic Ovary Syndrome (PCOS): A Multifaceted Hypothesis Towards the Disease with Potential Therapeutics
- Neurosteroids and Epileptogenesis
- Acquired Localized Longitudinal Pachyonychia and Onychomatrical Tumors: A Comparative Study to Onychomatricomas (5 Cases) and Onychocytic Matricomas (4 Cases)
- Guidelines for the management of vitiligo
- Temporal lobe epilepsy exacerbation during pharmacological inhibition of endogenous neurosteroid synthesis
- Immunological aspects and gender bias during respiratory viral infections including novel Coronavirus disease‐19 (COVID‐19): A scoping review
- Cutaneuos findings in patients with predialysis chronic kidney disease
- A novel nonsense mutation in the STS gene in a Pakistani family with X-linked recessive ichthyosis: including a very rare case of two homozygous female patients
- Disease severity scoring systems in dermatology
- A Homozygous Missense Variant in K25 Underlying Overlapping Phenotype with Woolly Hair and Dental Anomalies
- Kava-induced acute cutaneous toxicity: An increasingly recognized characteristic clinicohistologic pattern
- Hair loss due to methylphenidate use: A case study
- NOVEL CORONAVIRUS (SARS-COV-2): MOLECULAR BIOLOGY, PATHOGENESIS, PATHOBIOLOGY AND ADVANCES IN TREATMENT OF COVID-19 PATIENTS– AN UPDATE
- Effectiveness of Botulinum Toxin Type A for Trichodynia Associated with Hair Loss Disorders: A Retrospective Study
- Fast-tracked innovation: orforglipron approval under the FDA’s National Priority Voucher program
- Nanoformulated phytochemicals for PCOS: therapeutic potential, translational challenges, and future perspectives
- <i>Arachis hypogaea</i> L. Root Extract Mitigates Testosterone Propionate‐Induced Benign Prostatic Hyperplasia in ICR Mice by Suppressing Inflammation, Androgen Receptors, and Dihydrotestosterone
- Targeting the Gut Microbiota with Pro- and Postbiotics: Emerging Strategies against Alopecia
- Six-Month Quality of Life and Health Outcomes After Bariatric Surgery: A Prospective Cohort Study from Latvia
- Influencing hair regrowth with EGCG by targeting glycogen synthase kinase-3β activity: a molecular dynamics study
- Association Between Androgenetic Alopecia and Dyslipidemia in Male Patients: Evidence From a Hospital-Based Study
- Journal Club: Recent therapeutic developments in trichology
- The Relationship of Treatment Modality in Alopecia Areata with Life Quality, Anxiety, and Depression
- Glia-derived steroids modulate epileptogenesis in a model of temporal lobe epilepsy
- Disorders linked to insufficient androgen action in male children